CKW Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200
| Closed | -$47K | – | 186 |
|
|
2024
Q4 | $47K | Hold |
200
| – | – | 0.01% | 135 |
|
|
2024
Q3 | $55K | Hold |
200
| – | – | 0.01% | 130 |
|
|
2024
Q2 | $49K | Hold |
200
| – | – | 0.01% | 134 |
|
|
2024
Q1 | $31K | Hold |
200
| – | – | ﹤0.01% | 153 |
|
|
2023
Q4 | $38K | Hold |
200
| – | – | 0.01% | 146 |
|
|
2023
Q3 | $35K | Hold |
200
| – | – | 0.01% | 142 |
|
|
2023
Q2 | $38K | Hold |
200
| – | – | 0.01% | 137 |
|
|
2023
Q1 | $40K | Sell |
200
-50
| -20% | -$10.5K | 0.01% | 122 |
|
|
2022
Q4 | $59K | Sell |
250
-50
| -17% | -$10.7K | 0.01% | 106 |
|
|
2022
Q3 | $60K | Hold |
300
| – | – | 0.01% | 99 |
|
|
2022
Q2 | $44K | Hold |
300
| – | – | 0.01% | 119 |
|
|
2022
Q1 | $51K | Buy |
300
+100
| +50% | +$15.2K | 0.01% | 122 |
|
|
2021
Q4 | $30K | Hold |
200
| – | – | ﹤0.01% | 137 |
|
|
2021
Q3 | $39K | Hold |
200
| – | – | 0.01% | 130 |
|
|
2021
Q2 | $34K | Hold |
200
| – | – | 0.01% | 141 |
|
|
2021
Q1 | $28K | Hold |
200
| – | – | ﹤0.01% | 131 |
|
|
2020
Q4 | $26K | Sell |
200
-100
| -33% | -$13.4K | ﹤0.01% | 124 |
|
|
2020
Q3 | $43K | Hold |
300
| – | – | 0.01% | 102 |
|
|
2020
Q2 | $45K | Hold |
300
| – | – | 0.01% | 92 |
|
|
2020
Q1 | $31K | Hold |
300
| – | – | 0.01% | 101 |
|
|
2019
Q4 | $35K | Hold |
300
| – | – | 0.01% | 108 |
|
|
2019
Q3 | $22K | Hold |
300
| – | – | ﹤0.01% | 112 |
|
|
2019
Q2 | $22K | Hold |
300
| – | – | ﹤0.01% | 115 |
|
|
2019
Q1 | $28K | Hold |
300
| – | – | 0.01% | 124 |
|
|
2018
Q4 | $22K | Hold |
300
| – | – | ﹤0.01% | 131 |
|
|
2018
Q3 | $26K | Hold |
300
| – | – | ﹤0.01% | 131 |
|
|
2018
Q2 | $30K | Hold |
300
| – | – | 0.01% | 115 |
|
|
2018
Q1 | $30K | Sell |
300
-200
| -40% | -$25.8K | 0.01% | 102 |
|
|
2017
Q4 | $64K | Hold |
500
| – | – | 0.01% | 75 |
|
|
2017
Q3 | $59K | Hold |
500
| – | – | 0.01% | 78 |
|
|
2017
Q2 | $41K | Hold |
500
| – | – | 0.01% | 102 |
|
|
2017
Q1 | $26K | Hold |
500
| – | – | 0.01% | 115 |
|
|
2016
Q4 | $19K | Buy |
500
+300
| +150% | +$12.6K | 0.01% | 118 |
|
|
2016
Q3 | $14K | Buy |
+200
| New | +$14.1K | ﹤0.01% | 128 |
|
Other funds holding ALNY
RP
CKW Financial Group's ALNY Position: Q1 2025 in Review
CKW Financial Group sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2025, closing a stake of 200 shares — an estimated $47K sold.
CKW Financial Group first reported a position in ALNY in Q3 2016 and held it in 34 quarters. The position peaked at $64K in Q4 2017. 627 funds tracked by Wall St. Rank hold ALNY as of Q1 2025.
- CKW Financial Group reported no remaining Alnylam Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
- CKW Financial Group sold 200 Alnylam Pharmaceuticals shares in Q1 2025, an estimated $47K.
- CKW Financial Group first reported a position in Alnylam Pharmaceuticals in Q3 2016 and held it in 34 quarters.
- CKW Financial Group's Alnylam Pharmaceuticals position peaked at $64K in Q4 2017.
- 627 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2025.
Based on CKW Financial Group's 13F filing for Q1 2025, filed 16 May 2025.